Literature DB >> 10091760

Characterization of six cell lines established from human pancreatic adenocarcinomas.

M Kato1, Y Shimada, H Tanaka, R Hosotani, G Ohshio, K Ishizaki, M Imamura.   

Abstract

BACKGROUND: Six human pancreatic carcinoma cell lines, designated as KMP-1 to KMP-6, were established and maintained in vitro for > 3 years. All were derived from pancreatic ductal adenocarcinomas. The six cell lines originated from either primary pancreatic tumors, metastatic liver tumors, or metastases to lymph nodes.
METHODS: Each cell line was characterized by its morphology, doubling time, colony forming efficiency (CFE) on plastic dishes, tumorigenicity in nude mice, chromosomal analysis, and the amount of tumor markers secreted into the culture medium. Furthermore, mutations in the K-ras, p53, and p16/INK4a genes were analyzed.
RESULTS: All cell lines grew as an adhering monolayer and were cultured in medium supplemented with 2% fetal bovine serum. The doubling time ranged from 16-70 hours, and the CFE ranged from 0.1-11%. Subcutaneous transplantation of these carcinoma cells into nude mice resulted in the formation of tumors. Chromosomal analysis showed that the modal numbers ranged from 43-124, and each karyotype was unique. Each cell line secreted detectable amounts of squamous cell carcinoma antigen, carcinoembryonic antigen, carbohydrate antigen 19-9, Dupan-II, and cytokeratin 19 fragment, respectively. Genetic alterations of the K-ras, p53, and p16 genes were detected in six, three, and five, respectively, of the six cell lines.
CONCLUSIONS: The authors believe that these newly established pancreatic carcinoma cell lines will contribute to wide ranging studies regarding pancreatic carcinoma progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091760     DOI: 10.1002/(sici)1097-0142(19990215)85:4<832::aid-cncr10>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture.

Authors:  Kien Pham; Daniel Delitto; Andrea E Knowlton; Emily R Hartlage; Ricky Madhavan; David H Gonzalo; Ryan M Thomas; Kevin E Behrns; Thomas J George; Steven J Hughes; Shannon M Wallet; Chen Liu; Jose G Trevino
Journal:  Am J Pathol       Date:  2016-04-18       Impact factor: 4.307

2.  Comparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell.

Authors:  Jiang Chen; Xiao-Zhong Guo; Hong-Yu Li; Di Wang; Xiao-Dong Shao
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-02

3.  Bioluminescence imaging correlates with tumor serum marker, organ weights, histology, and human DNA levels during treatment of orthotopic tumor xenografts with antibodies.

Authors:  Thomas Poeschinger; Anja Renner; Thomas Weber; Werner Scheuer
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

Review 4.  Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved.

Authors:  Yutaka Shimada; Tetsuo Sudo; Shusuke Akamatsu; Takuro Sunada; Akira Myomoto; Kiyoshi Okano; Kazuharu Shimizu
Journal:  J Pers Med       Date:  2022-04-21

5.  Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor.

Authors:  Jiro Okami; Shoji Nakamori; Nobuaki Hiraoka; Masanori Tsujie; Nobuyasu Hayashi; Hirofumi Yamamoto; Yoshiyuki Fujiwara; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Novel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms.

Authors:  Stefan Fritz; Carlos Fernández-del Castillo; A John Iafrate; Mari Mino-Kenudson; Nancy Neyhard; Jennifer LaFemina; Amy Stirman; Andrew L Warshaw; Sarah P Thayer
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

7.  Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance.

Authors:  Ya-Jing Zhang; Chen-Lei Wen; Yu-Xin Qin; Xiao-Mei Tang; Min-Min Shi; Bai-Yong Shen; Yuan Fang
Journal:  Oncol Rep       Date:  2017-10-12       Impact factor: 3.906

8.  Characterization of human gastric adenocarcinoma cell lines established from peritoneal ascites.

Authors:  Bożenna Mytar; Małgorzata Stec; Rafał Szatanek; Kazimierz Węglarczyk; Katarzyna Szewczyk; Antoni Szczepanik; Grażyna Drabik; Jarek Baran; Maciej Siedlar; Monika Baj-Krzyworzeka
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.